BSE filing, NSE: VAKRANGEE. Summary written from the filing by ALFA Finder's alert engine.
Vakrangee Ltd: key numbers
- Share price
- ₹5.69
- Market cap
- ₹616.6 Cr
- Revenue (annual)
- ₹254.8 Cr
- Net profit (annual)
- ₹11.27 Cr
- P/E (TTM)
- 56.8×Sector 43.1×
- Promoter holding
- 40.04%-0.01% QoQ
- FII holding
- 0.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vakrangee Ltd
All →Vakrangee Investor Presentation: Key Takeaways
Q2 FY27 consolidated total income ₹6,408.9L (+10.7% QoQ), EBITDA ₹945.9L (15.3% margin), PAT ₹272.8L (+20.9% QoQ). Debt-free; quarterly GTV ₹12,976.8 Cr.
Vakrangee Results Update
Vakrangee reported Q2 FY27 PAT of ₹272.8 Lakh, up 20.9% QoQ, on 10.7% revenue growth. GTV reached ₹12,976 crore across 23,885 outlets.
Vakrangee Q2 FY27 Results: Net Profit ₹2.7 Cr, Down 10.0% YoY
Vakrangee Ltd reported revenue from operations of ₹61.7 Cr (-10.7% YoY) and net profit of ₹2.7 Cr (-10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.7 Cr · -10.0% YoY
Vakrangee Board Meeting Date
Vakrangee Limited has notified a board meeting on 28 October 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. This is an advance notice; the meeting has not yet been held.
Vakrangee Other Announcement
Vakrangee Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Vakrangee Annual General Meeting
Vakrangee shareholders passed six resolutions at its 36th AGM, including MD re-appointment and MOA alteration. The meeting was held via video conference on September 23, 2026.
Other board meeting date announcements
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.
Prerna Infrabuild Board Meeting Date
Prerna Infrabuild will convene its board on 04/11/2026 to consider quarter results. The meeting is proposed under Regulation 33 of the LODR.
JSL Industries Board Meeting Date
JSL Industries intimates that its Board will meet on 5 Nov 2026 to consider unaudited Q1/H1 results. The trading window closes from 1 Oct 2026 until results are public.